Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease

被引:90
|
作者
Morrow, David A. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Cardiovasc, TIMI Study Grp, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
angina; atherosclerosis; myocardial infarction; prevention; prognosis; C-REACTIVE PROTEIN; ELEVATION MYOCARDIAL-INFARCTION; BRAIN NATRIURETIC PEPTIDE; ASSOCIATION TASK-FORCE; 2002 GUIDELINE UPDATE; PROGNOSTIC VALUE; FOLLOW-UP; SCIENTIFIC STATEMENT; DIABETIC-PATIENTS; AMERICAN-COLLEGE;
D O I
10.1161/CIRCULATIONAHA.109.852749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Risk assessment is essential to effective medical decision making for secondary prevention. A variety of clinical tools, including the most basic elements of the clinical history and the physical examination, provide valuable information on prognosis. In addition, data from the ECG, laboratory testing, and noninvasive and invasive imaging are complementary with respect to prognosis and can aid in informing patients and their families, directing triage, and guiding medical therapy. An integrated approach to risk assessment is optimal, and simple clinical risk scores can assist the clinician in assimilating the diverse sources of data on prognosis. Emerging tools for risk assessment continue to provide new insights into the pathogenesis of atherothrombosis and may advance the extent to which the promise of personalized preventive medicine can be realized in our routine care of patients with CV disease. Although discussed in the context of CHD, these principles are important to the full spectrum of patients with peripheral and cerebrovascular atherosclerotic disease. © 2010 American Heart Association, Inc.
引用
收藏
页码:2681 / 2691
页数:11
相关论文
共 50 条
  • [1] Prediction of the risk of mortality using risk score in patients with coronary heart disease
    Chen, Qian
    Ding, Ding
    Zhang, Yuan
    Yang, Yunou
    Li, Qing
    Chen, Xuechen
    Hu, Gang
    Ling, Wenhua
    ONCOTARGET, 2016, 7 (49) : 81680 - 81690
  • [2] The impact of hyperhomocysteinemia as a cardiovascular risk factor in the prediction of coronary heart disease
    Geisel, J
    Hennen, B
    Hübner, U
    Knapp, JP
    Herrmann, W
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (11) : 1513 - 1517
  • [3] Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease
    Ndrepepa, Gjin
    Tada, Tomohisa
    Fusaro, Massimiliano
    Cassese, Salvatore
    King, Lamin
    Hadamitzky, Martin
    Haase, Hans-Ullrich
    Schoemig, Albert
    Kastrati, Adnan
    Pache, Juergen
    CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (12) : 1003 - 1011
  • [4] Simple risk models to predict cardiovascular death in patients with stable coronary artery disease
    Ford, Ian
    Robertson, Michele
    Greenlaw, Nicola
    Bauters, Christophe
    Lemesle, Gilles
    Sorbets, Emmanuel
    Ferrari, Roberto
    Tardif, Jean-Claude
    Tendera, Michal
    Fox, Kim
    Steg, Philippe Gabriel
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2021, 7 (03) : 287 - 294
  • [5] An Update on the Utility of Coronary Artery Calcium Scoring for Coronary Heart Disease and Cardiovascular Disease Risk Prediction
    Kianoush, Sina
    Al Rifai, Mahmoud
    Cainzos-Achirica, Miguel
    Umapathi, Priya
    Graham, Garth
    Blumenthal, Roger S.
    Nasir, Khurram
    Blaha, Michael J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (03) : 1 - 11
  • [6] B-type Natriuretic Peptides for the Prediction of Cardiovascular Events in Patients With Stable Coronary Heart Disease: The Heart and Soul Study
    Mishra, Rakesh K.
    Beatty, Alexis L.
    Jaganath, Rajesh
    Regan, Mathilda
    Wu, Alan H. B.
    Whooley, Mary A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (04):
  • [7] Growth-Differentiation Factor-15 for Risk Stratification in Patients With Stable and Unstable Coronary Heart Disease Results From the AtheroGene Study
    Kempf, Tibor
    Sinning, Jan-Malte
    Quint, Anja
    Bickel, Christoph
    Sinning, Christoph
    Wild, Philipp S.
    Schnabel, Renate
    Lubos, Edith
    Rupprecht, Hans J.
    Muenzel, Thomas
    Drexler, Helmut
    Blankenberg, Stefan
    Wollert, Kai C.
    CIRCULATION-CARDIOVASCULAR GENETICS, 2009, 2 (03) : 286 - 292
  • [8] Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
    Lindholm, Daniel
    Lindback, Johan
    Armstrong, Paul W.
    Budaj, Andrzej
    Cannon, Christopher P.
    Granger, Christopher B.
    Hagstrom, Emil
    Held, Claes
    Koenig, Wolfgang
    Ostlund, Ollie
    Stewart, Ralph A. H.
    Soffer, Joseph
    White, Harvey D.
    de Winter, Robbert J.
    Steg, Philippe Gabriel
    Siegbahn, Agneta
    Kleber, Marcus E.
    Dressel, Alexander
    Grammer, Tanja B.
    Maerz, Winfried
    Wallentin, Lars
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (07) : 813 - 826
  • [9] Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease
    Grandi, Norma Christine
    Breitling, Lutz Philipp
    Vossen, Carla Yvonne
    Hahmann, Harry
    Wuesten, Bernd
    Maerz, Winfried
    Rothenbacher, Dietrich
    Brenner, Hermann
    AMERICAN HEART JOURNAL, 2010, 159 (06) : 1044 - 1051
  • [10] Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study
    Tonkin, Andrew M.
    Blankenberg, Stefan
    Kirby, Adrienne
    Zeller, Tanja
    Colquhoun, David M.
    Funke-Kaiser, Anne
    Hague, Wendy
    Hunt, David
    Keech, Anthony C.
    Nestel, Paul
    Stewart, Ralph
    Sullivan, David R.
    Thompson, Peter L.
    West, Malcolm
    White, Harvey D.
    Simes, John
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 : 499 - 507